Y10S514/894 - CPC Classification Index

#1

20210053981

2021-02-25

ANTIVIRAL COMPOUNDS

#2

20200071337

2020-03-05

ANTIVIRAL COMPOUNDS

#3

20190276468

2019-09-12

Antiviral compounds

#4

20180244683

2018-08-30

ANTIVIRAL COMPOUNDS

#5

20180186806

2018-07-05

ANTIVIRAL COMPOUNDS

#6

20150141326

2015-05-21

Antiviral compounds

#7

20140309432

2014-10-16

Antiviral compounds

#8

20140178333

2014-06-26

Mutants of IL-29

#9

20140112885

2014-04-24

Antiviral compounds

#10

20130156732

2013-06-20

Antiviral compounds

#11

20130101554

2013-04-25

Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis

#12

20120213799

2012-08-23

Compositions and methods for treating inflammatory disorders

#13

20120114599

2012-05-10

Opioid and opioid-like compounds and uses thereof

#14

20120004161

2012-01-05

Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B

#15

20110268700

2011-11-03

Dosage regimens for HCV combination therapy

#16

20110237546

2011-09-29

Method for treating a mammal by administration of a compound having the ability to release CO

#17

20110236351

2011-09-29

Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950 for the Treatment of Hepatitis

#18

20100104531

2010-04-29

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#19

20090169508

2009-07-02

Opioid and opioid-like compounds and uses thereof

#20

20080279816

2008-11-13

Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B

#21

20080160112

2008-07-03

Pharmaceutical use of water-soluble fraction of

#22

20070292507

2007-12-20

Supportive treatment of liver disease

#23

20070264359

2007-11-15

Use of constituents for treating or preventing infections caused by hepatitis B-viruses

#24

20070218033

2007-09-20

Composition and method of treating hepatitis C

#25

20070172923

2007-07-26

Polynucleotide encoding an IL-28B polypeptide

#26

20070166282

2007-07-19

Homogeneous preparations of IL-28 and IL-29

#27

20070154446

2007-07-05

Homogeneous preparations of IL-28 and IL-29

#28

20070117967

2007-05-24

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#29

20070073044

2007-03-29

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#30

20070066810

2007-03-22

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#31

20070065406

2007-03-22

Homogeneous preparations of IL-28

#32

20070059804

2007-03-15

Polynucleotide encoding an IL-28B polypeptide

#33

20070059313

2007-03-15

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#34

20070055054

2007-03-08

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#35

20070055053

2007-03-08

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#36

20070055052

2007-03-08

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#37

20070055051

2007-03-08

Homogeneous preparations of IL-28 and IL-29

#38

20070054377

2007-03-08

Polynucleotide encoding an IL-28A polypeptide

#39

20070054376

2007-03-08

Polynucleotide encoding an IL-28A polypepide

#40

20070054375

2007-03-08

Polynucleotide encoding an IL-29 polypeptide

#41

20070054374

2007-03-08

Polynucleotide encoding an il-29 polypeptide

#42

20070053875

2007-03-08

Homogeneous preparations of IL-28A cysteine mutants

#43

20070049737

2007-03-01

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#44

20070048844

2007-03-01

Polynucleotide encoding an IL-28B polypeptide

#45

20070048843

2007-03-01

Homogeneous preparations of IL-28 and IL-29

#46

20070048277

2007-03-01

Homogeneous preparations of IL-28A mutants

#47

20070048276

2007-03-01

Homogeneous preparations of IL-28 A

#48

20070048275

2007-03-01

Homogeneous preparations of IL-28A cysteine mutants

#49

20070048274

2007-03-01

Homogeneous preparations of IL-28 and IL-29

#50

20070043210

2007-02-22

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#51

20070042471

2007-02-22

Polynucleotide encoding an IL-28A polypeptide

#52

20070042470

2007-02-22

Polynucleotide encoding an IL-28B polypeptide

#53

20070042469

2007-02-22

Polynucleotide encoding an IL-29 polypeptide

#54

20070041975

2007-02-22

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#55

20070041936

2007-02-22

Polynucleotide encoding an IL-28A polypeptide

#56

20060257365

2006-11-16

Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

#57

20060233890

2006-10-19

Method for treating a mammal by administration of a compound having the ability to release CO

#58

20060188477

2006-08-24

Method of treatment of viral hepatitis C with interferon alpha 5

#59

20060148900

2006-07-06

Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof

#60

20060045925

2006-03-02

Pharmaceutical use of Graptopetalum and related plants

#61

20050170027

2005-08-04

Hepatic disorder suppressant

#62

20050164942

2005-07-28

Method for treating a viral infection related or a chemical toxin related hepatic injury with deltorphin D

#63

20050163877

2005-07-28

Hepatic disorder suppressant

#64

20050163875

2005-07-28

Hepatic disorder suppressant

#65

20050123628

2005-06-09

Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis

#66

20050074429

2005-04-07

Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

#67

20050061678

2005-03-24

Treatment of humans with colloidal silver composition

#68

20050037012

2005-02-17

Homogeneous preparations of IL-28 and IL-29

#69

20050004053

2005-01-06

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection